Risk factors for temozolomide-induced myelotoxicity and effect of dose adjustments on prognosis of glioblastoma patients

被引：0

作者：

Grun, N. ^{[1
]}

Osinga, J. ^{[1
]}

Van der Vegt, A. ^{[1
]}

Van den Elzen, F. ^{[1
]}

Den Otter, C. ^{[1
]}

Postma, T. ^{[1
]}

Schuur, M. ^{[1
]}

Hamer, P. De Witt ^{[2
]}

Bruynzeel, A. ^{[3
]}

Lagerwaard, F. ^{[3
]}

Van Linde, M. ^{[4
]}

Bartelink, I. ^{[5
]}

Lissenberg-Witte, B. ^{[6
]}

Kouwenhoven, M. ^{[1
]}

机构：

[1] Amsterdam UMC Locat VUmc, Dept Neurol, Amsterdam, Netherlands

[2] Amsterdam UMC Locat VUmc, Dept Neurosurg, Amsterdam, Netherlands

[3] Amsterdam UMC Locat VUmc, Dept Radiotherapy, Amsterdam, Netherlands

[4] Amsterdam UMC Locat VUmc, Dept Med Oncol, Amsterdam, Netherlands

[5] Amsterdam UMC Locat VUmc, Dept Farmacy, Amsterdam, Netherlands

[6] Amsterdam UMC Locat VUmc, Dept Biostat & Data Sci, Amsterdam, Netherlands

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

OPR-155

引用

页码：168 / 168

页数：1

共 50 条

[1] PROLONGED TRANSFUSION-DEPENDENT TEMOZOLOMIDE-INDUCED THROMBOCYTOPAENIA IN GLIOBLASTOMA: RISK FACTORS REMAIN ELUSIVE
Ismail, Nashwah
Patel, Karan
Colaco, Rovel
Borst, Gerben
Milanovic, Dusan
McBain, Catherine
[J]. NEURO-ONCOLOGY, 2022, 24 : 23 - 23
[2] Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma
Kohsaka, Shinji
Takahashi, Kenta
Wang, Lei
Tanino, Mishie
Kimura, Taichi
Nishihara, Hiroshi
Tanaka, Shinya
[J]. CANCER LETTERS, 2013, 331 (01) : 68 - 75
[3] RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825
Zhou, Renke
Scheurer, Michael
Vera-Bolanos, Elizabeth
Gilbert, Mark
Bondy, Melissa
Sulman, Eric
Hilsenbeck, Sue
Wendland, Merideth
Brachman, David
Roof, Kevin
Komaki, Ritsuko
Deutsch, Melvin
Andrews, David
Anderson, Bethany
Lee, R. Jeffrey
Pugh, Stephanie
Armstrong, Terri
[J]. NEURO-ONCOLOGY, 2014, 16
[4] Characterization and Prognosis of Temozolomide-Induced Aplastic Anemia
Park, Albert K.
Waheed, Anem
Forst, Deborah A.
Al-Samkari, Hanny
[J]. BLOOD, 2021, 138
[5] Glioblastoma stem cells resistant to temozolomide-induced autophagy
FU Jun LIU Zhigang LIU Xiaomei CHEN Furong SHI Hongliu PANG Jesse Chungsean NG Hokeung CHEN Zhongping State Key Laboratory for Cancer Research in Southern China and Department of NeurosurgeryNeurooncologyCancer CenterSun Yatsen UniversityGuangzhouGuangdong ChinaDepartment of Anatomical Cellular PathologyChinese University of Hong KongShatinNTHong KongChina
[J]. 中华医学杂志(英文版), 2009, (11) : 1255 - 1259
[6] Glioblastoma stem cells resistant to temozolomide-induced autophagy
Fu Jun
Liu Zhi-gang
Liu Xiao-mei
Chen Fu-rong
Shi Hong-liu
Pang, Jesse Chung-sean
Ng, Ho-keung
Chen Zhong-ping
[J]. CHINESE MEDICAL JOURNAL, 2009, 122 (11) : 1255 - 1259
[7] Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma The PLATUM trial
Le Rhun, Emilie
Devos, Patrick
Houillier, Caroline
Cartalat, Stephanie
Chinot, Olivier
Di Stefano, Anna Luisa
Lepage, Clement
Reyns, Nicolas
Dubois, Francois
Weller, Michael
[J]. NEUROLOGY, 2019, 93 (19) : E1799 - E1806
[8] Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients
Saito, Taiichi
Sugiyama, Kazuhiko
Hama, Seiji
Yamasaki, Fumiyuki
Takayasu, Takeshi
Nosaka, Ryo
Muragaki, Yoshihiro
Kawamata, Takakazu
Kurisu, Kaoru
[J]. NEUROSURGICAL REVIEW, 2018, 41 (02) : 621 - 628
[9] Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients
Taiichi Saito
Kazuhiko Sugiyama
Seiji Hama
Fumiyuki Yamasaki
Takeshi Takayasu
Ryo Nosaka
Yoshihiro Muragaki
Takakazu Kawamata
Kaoru Kurisu
[J]. Neurosurgical Review, 2018, 41 : 621 - 628
[10] Temozolomide-induced glioblastoma cell death through autophagy and apoptosis
Lee, Chin-Cheng
Shih, Chwen-Ming
Lin, Chein-Ju
Shih, Yung-Leun
Wei, Chih-Peng
Tsai, Ming-Dar
[J]. BRAIN PATHOLOGY, 2006, 16 : S29 - S29

← 1 2 3 4 5 →